Europe Thyroid Cancer Diagnostics Market Size & Outlook

The thyroid cancer diagnostics market in Europe is expected to reach a projected revenue of US$ 1,148.8 million by 2030. A compound annual growth rate of 4.5% is expected of Europe thyroid cancer diagnostics market from 2025 to 2030.
Revenue, 2024 (US$M)
$884.3
Forecast, 2030 (US$M)
$1,148.8
CAGR, 2025 - 2030
4.5%
Report Coverage
Europe

Europe thyroid cancer diagnostics market highlights

  • The Europe thyroid cancer diagnostics market generated a revenue of USD 747.5 million in 2019.
  • The market is expected to grow at a CAGR of 4.9% from 2020 to 2027.
  • In terms of segment, papillary carcinoma was the largest revenue generating type in 2019.
  • Follicular Carcinoma is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2020 to 2027.


Europe data book summary

Market revenue in 2019USD 747.5 million
Market revenue in 2027USD 1,096.7 million
Growth rate4.9% (CAGR from 2019 to 2027)
Largest segmentPapillary carcinoma
Fastest growing segmentFollicular Carcinoma
Historical data covered2016 - 2018
Base year for estimation2019
Forecast period covered2020 - 2027
Quantitative unitsRevenue in USD million
Market segmentationPapillary Carcinoma, Follicular Carcinoma
Key market players worldwideAbbott Laboratories, Roche, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, GE Aerospace, Koninklijke Philips NV, Toshiba Corporation, Agilent Technologies Inc, Illumina Inc


Other key industry trends

  • In terms of revenue, Europe region accounted for 29.8% of the global thyroid cancer diagnostics market in 2019.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2027.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 920.0 million by 2027.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Thyroid Cancer Diagnostics Market Scope

Thyroid cancer diagnostics market segmentation & scope
Papillary Carcinoma
Follicular Carcinoma
Others
Blood Test
Imaging
Biopsy
Others
Hospital Laboratories
Cancer Diagnostic Centers
Research Institutes
Others

Thyroid Cancer Diagnostics Market Companies

Name Profile # Employees HQ Website

Europe thyroid cancer diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thyroid cancer diagnostics market will help companies and investors design strategic landscapes.


Papillary carcinoma was the largest segment with a revenue share of 80.12% in 2024. Horizon Databook has segmented the Europe thyroid cancer diagnostics market based on papillary carcinoma, follicular carcinoma covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe thyroid cancer diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe thyroid cancer diagnostics market databook

  • Our clientele includes a mix of thyroid cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe thyroid cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe thyroid cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe thyroid cancer diagnostics market size, by country, 2018-2030 (US$M)

Europe Thyroid Cancer Diagnostics Market Outlook Share, 2024 & 2030 (US$M)

Europe thyroid cancer diagnostics market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more